eltrombopag
TRA103452
Phase 3 small_molecule completed
Quick answer
eltrombopag for Purpura, Thrombocytopaenic, Idiopathic is a Phase 3 program (small_molecule) at GlaxoSmithKline with 2 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Purpura, Thrombocytopaenic, Idiopathic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed